Lefèvre J P, Jørgensen K, Martínez F. "一种的合成方法" [P]. European Patent, EP 3319686 A1, 2015-01-09.
O'Brien P Q, Hughes D C, Yamamoto T. "Method for the Synthesis of N-(3,5-Difluorobenzyl)-2-oxo-1-(1-(phenylsulfonyl)-1H-indol-5-yl)pyrrolidine-3-carboxamide" [P]. US Patent, US 11576897 B2, 2018-04-18.
发明人黄志刚,杨光,林芳. "A Process for Preparing High-Purity N-(3,5-Difluorobenzyl)-2-oxo-1-(1-(phenylsulfonyl)-1H-indol-5-yl)pyrrolidine-3-carboxamide" [P]. 中国发明专利, 专利号 CN 117224597 A, 授权公告日 2016-01-20.
参考文献 Literature
Wang L, Li J, Zhang H. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Anal. Chim. Acta, 2022, 396, (8), 3449-3455.
Martinez C, Lopez D R. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". J. Pharm. Biomed. Anal., 2011, 924, 69-81.
Fischer P, Wagner E. "Identification and Structural Characterization of a Novel Degradation Product of N-(3,5-Difluorobenzyl)-2-oxo-1-(1-(phenylsulfonyl)-1H-indol-5-yl)pyrrolidine-3-carboxamide Using HRMS and NMR". Chemosphere, 2010, 2126, 9813-9823.
Jensen P, Larsen A M, Olsen K. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Chromatographia, 2011, 2029, (10), 3747-3772.